SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001628280-21-007363
Filing Date
2021-04-22
Accepted
2021-04-22 16:07:21
Documents
3
Period of Report
2021-04-22

Document Format Files

Seq Description Document Type Size
1 DEF 14A a2021def14a.htm DEF 14A 495131
2 GRAPHIC corcepttherapeuticsincorpo.jpg GRAPHIC 241763
3 GRAPHIC corcepttherapeuticsincorpoa.jpg GRAPHIC 377890
  Complete submission text file 0001628280-21-007363.txt   1349770
Mailing Address 149 COMMONWEALTH DRIVE MENLO PARK CA 94025
Business Address 149 COMMONWEALTH DRIVE MENLO PARK CA 94025 650.688.8803
CORCEPT THERAPEUTICS INC (Filer) CIK: 0001088856 (see all company filings)

IRS No.: 770487658 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 000-50679 | Film No.: 21844853
SIC: 2834 Pharmaceutical Preparations